Our objective is to deepen the understanding of chemical transformations and complex biological phenomena at the molecular level. This understanding enables the design of new reactions and processes that expand chemical space and provide access to previously inaccessible compounds. A better understanding of complex biological phenomena is achieved through the development of cutting-edge chemical tools, sometimes complemented with artificial intelligence strategies, that enable the visualization, modification, or functional control of (bio)molecules.
Our objective is to deepen the understanding of chemical transformations and complex biological phenomena at the molecular level. This understanding enables the design of new reactions and processes that expand chemical space and provide access to previously inaccessible compounds. A better understanding of complex biological phenomena is achieved through the development of cutting-edge chemical tools, sometimes complemented with artificial intelligence strategies, that enable the visualization, modification, or functional control of (bio)molecules.
We develop bioassays and minimally invasive monitoring tools, and identify biomarkers to improve disease detection and monitoring. Our main objective is to enhance diagnostic precision and disease monitoring through the use of biosensors, advanced spectrometry, in vivo imaging, and a wide range of screening strategies.
We develop innovative therapeutic strategies from the molecular to the preclinical level. Our research encompasses drug discovery, design of bioactive molecules, nanomedicine, and advanced delivery platforms, supported by AI-driven optimization and a wide range of biochemical, cellular, and animal studies.
